Interleukin-4 (IL-4) is a tumor immunology regulator cytokine that exhibited strong anti-tumor immunity in preclinical experiments, such as the case of Kaposi sarcoma cells (16, 80). This evidence concerns the gene IL4 and Kaposi's sarcoma.